Most Recent
Elderly victims of Ponzi schemer Bradley Sherwin have told the government's class action inquiry of their "horrendous class action journey", which led to a "pathetic outcome" in which the majority of a $12 million settlement with the Bank of Queensland went to the law firm and funder behind the case.
Uber has once again attempted to put the brakes on a landmark class action which alleges the ride-sharing giant engaged in a conspiracy to steal business from taxi and limousine drivers across four states, telling a court of appeal that the trial judge wrongly departed from prevailing laws.
US food giant Kraft-Heinz wants the High Court to hear its intellectual property stoush with Bega after twice losing the battle over the right to use its peanut butter trade dress in Australia.
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
A plaintiffs law firm has fired off another class action against Uber after losing a bid to amend the group definition in a class action brought against the ride-sharing giant last year.
Global law firm Jones Day has nabbed former Herbert Smith Freehills partner Matthew Bull to boost the ranks of its antitrust and competition practice.
Kraft has lost an appeal in its high-stakes legal battle against Bega over the right to use its distinctive peanut butter trade dress in Australia.
A judge has denied a bid by the applicant in a massive class action against ride-sharing giant Uber to amend the group definition to include successors and assignees of those with claims, saying the request was made too late and that it was not clear who exactly would be included in the new group.
A judge has ordered the Rinehart family to enter mediation in their feud over a $4 billion trust, saying it was "overwhelmingly in the interests of the administration of justice" to seek an end to the long-running and bitter dispute.
A judge has granted a request by Otsuka and Bristol-Myers Squibbs to withdraw admissions in proceedings brought by Generic Health seeking damages, after the generic drug maker was temporarily blocked from selling a generic version of antipsychotic Abilify in a patent dispute in which it ultimately triumphed.